Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Cloonan currently holds 577,392 shares of bluebird bio, Inc. (BLUE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Cloonan has been a net seller of BLUE stock. They have purchased $0 and sold $10.7M worth of shares.
Michael Cloonan's most recent insider trade was on Oct 21, 2025, when they sold 30,049 shares at $6.11 per share.
Michael Cloonan serves as Executive at bluebird bio, Inc. (BLUE). They have executed 29 insider transactions totaling $10.7M over their tenure at the company.
Michael Cloonan holds the position of Executive at bluebird bio, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Michael Cloonan has shown a selling trading pattern, with $0 in total purchases and $10.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael Cloonan was on May 22, 2019, when they sold $4.4M worth of SAGE shares. This transaction involved 25,000 shares at $175.00 per share.
Michael Cloonan currently owns 577,392 shares of bluebird bio, Inc. (BLUE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Cloonan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Cloonan has 29 Form 4 filings on record as an insider at bluebird bio, Inc..
Set alerts for Michael Cloonan and 40,000+ other insiders.